U.S. Genetic Testing Market
- 2026 年市場規模
- USD 5,290.6 Mn
- 2033 年預估規模
- USD 9,150.7 Mn
- 年複合成長率 CAGR
- 8.1%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
U.S. Genetic Testing Market, By Offering (Products and Services), By Type of Testing (Single gene testing, Genetic testing panels, Large-scale genomic testing, and Others), By Technology (Next Generation Sequencing (NGS), PCR-Based Technologies, SNP Chip Technology, and Supporting Technologies), By Application (Prenatal and Newborn Testing, Ancestry and Ethnicity Testing, Diagnostic Testing, and Others), By End User: Hospitals, Independent and Diagnostic Laboratories, Academic and Research Institutes, and Direct-to-Consumer
報告摘要
The U.S. genetic testing market is estimated to be valued at USD 5,290.6 Mn in 2026 and is expected to reach USD 9,150.7 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.1% from 2026 to 2033. Genetic testing is a key segment in screening DNA, RNA, chromosomes, proteins, or metabolites to detect genetic mutations, genes, or chromosome alterations that cause or are related to inherited disorders. Genetic tests also analyze the susceptibility to certain diseases, help decide treatment for an individual and are sometimes used in legal settings or medical investigations. They are widely being incorporated into clinical diagnostics, reproductive health, oncology, orphan/rare diseases, and preventative care and screening programs.
Genetic testing services are sold through clinical and public diagnostic and counseling sites, hospitals, research institutions, and direct-to-consumer businesses, aiming to enable consumers to obtain meaningful insights from their genomic information and assist health care providers in making more targeted treatment decisions. The trend toward the adoption of genomic data in clinical care is paving the way for genetic tests to play a larger role in U.S. precision medicine.
Market Dynamics
The U.S. genetic testing market is primarily driven by the expanding applications of precision medicine; rising incidences of genetic disorders and cancer; and a surge in demand for early and accurate detection of diseases. Moreover, healthcare professionals are gradually adopting genetic testing for pre-screening of the predisposed disease, planning targeted therapies and personalized treatment management, due to constant development in next-generation sequencing technologies (NGS).
However, the growth of market is limited by factors such as high price of progressive genetic tests, low reimbursement for many tests, privacy and security concern over genetic data, and regulatory framework associated with tests validation, utility, and data processing. Nevertheless, there are abundant growth prospects due to factors such increasing access of consumer based genetic testing and integration of bioinformatics with genomic profiling. The availability of home-based testing systems and more proficient methods to interpret genomic variations also contribute to overall market growth in coming years.
Key Features of the Study
• This report provides in-depth analysis of the U.S. genetic testing market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the U.S. genetic testing market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Illumina, Quest Diagnostics, Labcorp Genetics, Natera, Myriad Genetics, GeneDx, Fulgent Genetics, Ambry Genetics, Exact Sciences, and 23andMe
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The U.S. genetic testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. genetic testing market
Market Segmentation
• Offering Insights (Revenue, USD Mn, 2021 - 2033)
o Products
o Services
• Type of Testing Insights (Revenue, USD Mn, 2021 - 2033)
o Single gene testing
o Genetic testing panels
o Large-scale genomic testing
o Others
• Technology Insights (Revenue, USD Mn, 2021 - 2033)
o Next Generation Sequencing (NGS)
o PCR-Based Technologies
o SNP Chip Technology
o Supporting Technologies
• Application Insights (Revenue, USD Mn, 2021 - 2033)
o Prenatal and Newborn Testing
o Ancestry and Ethnicity Testing
o Diagnostic Testing
o Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals
o Independent and Diagnostic Laboratories
o Academic and Research Institutes
o Direct-to-Consumer
• Key Players Insights
o Illumina, Inc.
o Quest Diagnostics
o Labcorp Genetics
o Natera
o Myriad Genetics
o GeneDx
o Fulgent Genetics
o Ambry Genetics
o Exact Sciences
o 23andMe
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
U.S. Genetic Testing Market, By Offering
U.S. Genetic Testing Market, By Type of Test
U.S. Genetic Testing Market, By Technology
U.S. Genetic Testing Market, By Application
U.S. Genetic Testing Market, By End User
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Industry Trends
4. U.S. Genetic Testing Market, By Offering, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Products
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. U.S. Genetic Testing Market, By Type of Test, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Single gene testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Genetic testing panels
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Large-scale genomic testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. U.S. Genetic Testing Market, By Technology, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Next Generation Sequencing (NGS)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o PCR-Based Technologies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o SNP Chip Technology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Supporting Technologies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Genetic Testing Market, By Application, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Prenatal and Newborn Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Ancestry and Ethnicity Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Diagnostic Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Genetic Testing Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Independent and Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Academic and Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Direct-to-Consumer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Competitive Landscape
o Illumina, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Quest Diagnostics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Labcorp Genetics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Natera
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Myriad Genetics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o GeneDx
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Fulgent Genetics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Ambry Genetics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Exact Sciences
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o 23andMe
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
11. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Genetic Testing Market' – U.S. forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們